genzyme corp said patent office has approved patent for company method testing for serum alpha amylase indicator pancreatic disease patent strengthens genzyme proprietary position leading independent supplier diagnostic enzymes and substrates henri temeer genzyme president said company said technology combines unique substrate with two indicator enzymes diagnostic assay measure serum amylase levels genzyme said since 1985 has entered into several licensing agreements for technology with amylase test kit makers reuter 